Compare AXS & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AXS | BRKR |
|---|---|---|
| Founded | 2001 | 1960 |
| Country | Bermuda | United States |
| Employees | 1876 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 5.6B |
| IPO Year | N/A | 2000 |
| Metric | AXS | BRKR |
|---|---|---|
| Price | $100.91 | $33.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $121.86 | $49.54 |
| AVG Volume (30 Days) | 578.7K | ★ 2.2M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 1.75% | 0.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $4.36 | $6.27 |
| Revenue Next Year | $6.20 | $3.78 |
| P/E Ratio | $8.43 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $84.81 | $28.53 |
| 52 Week High | $110.34 | $56.22 |
| Indicator | AXS | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 42.50 | 27.40 |
| Support Level | $99.15 | $29.54 |
| Resistance Level | $103.65 | $35.15 |
| Average True Range (ATR) | 2.23 | 1.49 |
| MACD | -0.44 | -0.21 |
| Stochastic Oscillator | 25.44 | 5.10 |
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.